S100B and response to treatment in major depression: a pilot study

Author： Arolt V. Peters M. Erfurth A. Wiesmann M. Missler U. Rudolf S. Kirchner H. Rothermundt M.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.13, Iss.4, 2003-08, pp. : 235-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study

By Machado-Vieira R. Lara D.R. Portela L.V.C. Goncalves C.A. Soares J.C. Kapczinski F. Souza D.O.

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 269-272

Elsevier

Access to resources Recommend Favorite

Remission Rates with Milnacipran 100 Mg/Day and 150 Mg/Day in the Long-Term Treatment of Major Depression

By Okumura Kazuo

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 135-142

Adis International

Access to resources Recommend Favorite

Catecholaminergic Strategies for the Treatment of Major Depression

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Neutrophil 2 -adrenoceptor function in major depression: G s coupling, effects of imipramine and relationship to treatment outcome

By Gurguis G.N.M. Vo S.P. Griffith J.M. Rush A.J.

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 135-144

Elsevier

Access to resources Recommend Favorite

An increased hypothermic response to buspirone in patients with major depression

By Navinés Ricard Gómez-Gil Esther Martín-Santos Rocío Martínez de Osaba María Ímaz Maria Gastó Cristóbal

Psychopharmacology, Vol. 188, Iss. 2, 2006-10 ,pp. : 258-260

Springer Publishing Company

Access to resources Recommend Favorite